Singapore markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
878.95-27.59 (-3.04%)
As of 10:44AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts21202625
Avg. Estimate10.0810.8745.0347.59
Low estimate8.569.2736.4841.73
High estimate11.6212.652.656.4
Year ago EPS10.0910.2443.7945.03
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts20182625
Avg. Estimate3.22B3.4B13.93B14.97B
Low estimate3.07B3.15B13.04B13.69B
High estimate3.51B3.65B14.75B17.18B
Year ago sales3BN/A13.12B13.93B
Sales growth (year/est)7.20%N/A6.20%7.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS9.569.8410.7210.73
Actual EPS10.0910.2411.5911.86
Difference0.530.40.871.13
Surprise %5.50%4.10%8.10%10.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate10.0810.8745.0347.59
7 days ago10.1211.0145.2247.53
30 days ago9.9610.9544.7847.27
60 days ago10.0211.0644.8547.26
90 days ago10.411.2244.7348.01
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1N/A12
Up last 30 days6587
Down last 7 daysN/AN/AN/AN/A
Down last 30 days112N/A
Growth estimatesREGNIndustrySector(s)S&P 500
Current qtr.-0.10%N/AN/AN/A
Next qtr.6.20%N/AN/AN/A
Current year2.80%N/AN/AN/A
Next year5.70%N/AN/AN/A
Next 5 years (per annum)7.36%N/AN/AN/A
Past 5 years (per annum)17.45%N/AN/AN/A